Wikidata

(Q63534256)

English

Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC

clinical trial

In more languages

Statements

short name
CONTESSA (English)
0 references
title
A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel Plus a Reduced Dose of Capecitabine Versus Capecitabine Alone in Patients With HER2 Negative, HR Positive, Locally Advanced or Metastatic Breast Cancer Previously Treated With a Taxane (English)
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
France
0 references
Germany
0 references
Hungary
0 references
Italy
0 references
Poland
0 references
Singapore
0 references
Spain
0 references
Taiwan
0 references
Thailand
0 references
Ukraine
0 references
United Kingdom
0 references
start time
21 December 2017
0 references
end time
September 2020
0 references
number of participants
600
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63534256&oldid=1857243476"